SNX2-ABL1 fusion
|
Childhood B Acute Lymphoblastic Leukemia
|
SNX2-ABL1 fusion
|
Childhood B Acute Lymphoblastic Leukemia
|
dasatinib Resistant: C4 – Case Studies
|
dasatinib Resistant: C4 – Case Studies
|
SNX2-ABL1 fusion
|
B Acute Lymphoblastic Leukemia
|
SNX2-ABL1 fusion
|
B Acute Lymphoblastic Leukemia
|
imatinib Sensitive: C4 – Case Studies
|
imatinib Sensitive: C4 – Case Studies
|
SNX2-ABL1 fusion
|
ALL
|
SNX2-ABL1 fusion
|
ALL
|
imatinib Resistant: D – Preclinical
|
imatinib Resistant: D – Preclinical
|
SNX2-ABL1 fusion
|
ALL
|
SNX2-ABL1 fusion
|
ALL
|
dasatinib Resistant: D – Preclinical
|
dasatinib Resistant: D – Preclinical
|